Techniki nerkozastępcze
      
   
 
 
Techniki nerkozastępcze u progu XXI wieku
 
Paweł Dyras, Jacek A. Pietrzyk
 
Piśmiennictwo
  1. Henderson L.W.: Dialysis in the 2lst Century. Am. J. Kidney Dis.1996, 6, 951. "
  2. Wetzels J.F., Burke TJ., Schrier R.W.: Calcium channel blockers: Protective effects in ischemic acute renal failure. Ren. Fai1.1992, 14, 327.
  3. Wagner K., Albrecht S, Neumayer HH.: Prevention of post- transplant acute tubular necrosis by the calcium antagonist diltiazem: A prospective, randomized study. Am. J. Nephrol. 1987, 7, 287.
  4. Edelstain C.L., Yaqoob M.M., Alkhunaizi A. i wsp.: Modulation of hypoxia induced calpain activity in renal proximal tubules. Kidney Int. 1996, 50, 1150.
  5. Yaqoob M.M., Edelstein C.L., Wieder E.D. i wsp.: Nitric oxide kinetics in during hypoxia in proximal tubules: Effects of acidosis and glycine. Kidney Int. 1996, 49, 1314.
  6. Noiri E., Gailit J., Sheth D. i wsp.: Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney Int. 1994, 46, 1050.
  7. Allgren R.L., Marbury T.C., Rahman S.N. i wsp.: Anaritide in acute tubular necrosis. N. Engl. J. Med. 1997, 336, 828.
  8. Franklin S., Moulton M., Hammerman M.R., Miller S.B.: Sustained improvement of renal function and amelioration of symptoms in patients with chronic renal failure treated with insulin-like growth factor-1. JASN 1995, 6, 387.
  9. Hakim R.M., Lazarus J.M.: Initiation of dialysis. JASN 1995, 6, 1319. 10. Henderson L.W.: Why do we use "clearance"? Blood Purification 1995, 13, 283.
  10. Chama B., Calemard E., Ruffet N. i wsp.: Survival as an index of adequacy of dialysis. Kidney Int. 1992, 41, 1286.
  11. Hakim R.M., Wingard R.L., Parker R.A.: Effect of dialysis membranes in the treatment of patients with acute renal failure. N. Engl. J. Med. 1994, 331, 1338.
  12. Geyo F., Teramura T, Ei I. i wsp.: Long-term clinical evaluation of an adsorbent column (BM-01) of direct hemoperfusion type for B2-microglobulin on the treatment of dialysis-related amyloidosis. Artif. Organs 1995, 19, 1222.
  13. Nagy J.A., Shockley T.R., Masse E.M. i wsp.: Mesothelial cell mediated gene therapy: Feasibility of an ex vivo strategy. Gene Ther. 1995, 2, 402.
 
   
 
 
 
 
 
 
 
 
DIALIZOTERAPIA DZIECIĘCA
      
           
         
.